Tuesday, September 23, 2025
HomeIndustriesBiotechnology

Biotechnology

ZielBio Receives Orphan Drug Designation for ZB131 for the Treatment of Pancreatic Cancer

ZielBio, Inc., a clinical-stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative drug discovery platform, announced that the...

Cellectis Announces First Dosing of a Patient with its In-house Manufactured Product Candidate UCART22

Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced that for the first time, a...

New Publication Demonstrates Rapid Esophageal Regeneration using the Biostage Esophageal Implant

Biostage, Inc., a cell-therapy biotechnology company with successful first-in-human experience repairing the esophagus after the cancer in the patient's esophagus had been surgically removed*...

Akebia Therapeutics Received Interim Response to Appeal for Vadadustat

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, announced that the company received...

Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application

Neurocrine Biosciences, Inc., a leading neuroscience-focused biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application...
0FansLike
0FollowersFollow
spot_img

Hot Topics